A phase II multicenter, double-blind, randomized trial to compare anastrozole plus gefinitib with anastrozole plus placebo in postmenopausal women with hormone receptor-positive (HR plus ) metastatic breast cancer (MBC)

被引：16
|
作者：
Cristofanilli, M.
Valero, V.
Mangalik, A.
Rabinowitz, I.
Arena, F. P.
Kroener, J. F.
Curcio, E.
Watkins, C.
Magill, P.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ New Mexico, UNM Canc Ctr, Albuquerque, NM 87131 USA
[3] Arena Oncol Associates, New York, NY USA
[4] Scripps Hlth, San Diego, CA USA
[5] AstraZeneca, Macclesfield, Cheshire, England
[6] Grp Trabajo Oncol Med, Caracas, Venezuela
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.1012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1012
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II, Randomized Trial to Compare Anastrozole Combined with Gefitinib or Placebo in Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
    Cristofanilli, Massimo
    Valero, Vicente
    Mangalik, Aroop
    Royce, Melanie
    Rabinowitz, Ian
    Arena, Francis P.
    Kroener, Joan F.
    Curcio, Elizabeth
    Watkins, Claire
    Bacus, Sarah
    Cora, Elsa M.
    Anderson, Elizabeth
    Magill, Patrick J.
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (06) : 1904 - 1914
  • [2] Results of a randomized double blind trial of neoadjuvant anastrozole plus placebo vs anastrozole plus saracatinib for ER plus postmenopausal breast cancer
    Slingerland, J. m
    Mark, P.
    Hurley, J.
    Net, J.
    Collado-Mesa, F.
    Lippman, M.
    Avisar, E.
    Yepes, M.
    Jorda, M.
    Gomez, C.
    [J]. CANCER RESEARCH, 2019, 79 (04)
  • [3] Src Kinase Inhibition with AZD0530 Plus Anastrozole in Postmenopausal Hormone Receptor Positive (HR plus ) Metastatic Breast Cancer (MBC)
    Pegram, M.
    Silva, O.
    Higgins, C.
    Tukia, K.
    Avisar, E.
    Stuart, M.
    Slingerland, J.
    [J]. CANCER RESEARCH, 2010, 70
  • [4] Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor-Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
    Carlson, Robert W.
    Theriault, Richard
    Schurman, Christine M.
    Rivera, Edgardo
    Chung, Cathie T.
    Phan, See-Chun
    Arun, Banu
    Dice, Kristine
    Chiv, Vivian Y.
    Green, Marjorie
    Valero, Vicente
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3917 - 3921
  • [5] A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
    Robert W. Carlson
    Anne O’Neill
    Tatiana Vidaurre
    Henry L. Gomez
    Sunil S. Badve
    George W. Sledge
    [J]. Breast Cancer Research and Treatment, 2012, 133 : 1049 - 1056
  • [6] A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
    Carlson, Robert W.
    O'Neill, Anne
    Vidaurre, Tatiana
    Gomez, Henry L.
    Badve, Sunil S.
    Sledge, George W.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 1049 - 1056
  • [7] Randomized phase II trial of gefitinib plus anastrozole or fulvestrant in postmenopausal, metastatic breast cancer
    Carlson, R. W.
    O'Neill, A.
    Vidaurre, T.
    Gomez, H. L.
    Badve, S.
    Sledge, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Phase IB pharmacokinetic (PK) study of Src kinase inhibitor AZD0530 plus anastrozole in postmenopausal hormone receptor positive (HR plus ) metatatic breast cancer (MBC)
    Pegram, M. D.
    Silva, O. E.
    Higgins, C.
    Tukia, K.
    Stuart, M.
    Slingerland, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] Fulvestrant plus anastrozole as neoadjuvant therapy in postmenopausal women with hormone receptor positive early breast cancer
    Khan, Q. J.
    Barr, J. A.
    Britt, A. S.
    Kimler, B. F.
    Connor, C. S.
    McGinness, M.
    Mammen, J. M. V.
    Wagner, J. L.
    Amin, A.
    Springer, M.
    Baccaray, S.
    Fabian, C. J.
    Sing, A. P.
    Sharma, P.
    [J]. CANCER RESEARCH, 2016, 76
  • [10] Goserelin plus anastrozole for the treatment of premenopausal women with hormone receptor positive, recurrent/metastatic breast cancer
    Carlson, RW
    Schurmann, CM
    Rivera, E
    Chung, CT
    Phan, SC
    Dice, EK
    Arun, B
    Thomas, E
    Valero, V
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S237 - S238
12345